- Home
- ASTH vs AZTA Comparison
ASTH vs AZTA Comparison
Compare ASTH & AZTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASTH
- AZTA
- Stock Information
- Founded
- ASTH 1994
- AZTA 1978
- Country
- ASTH United States
- AZTA United States
- Employees
- ASTH N/A
- AZTA N/A
- Industry
- ASTH Professional Services
- AZTA Industrial Machinery/Components
- Sector
- ASTH Consumer Discretionary
- AZTA Technology
- Exchange
- ASTH Nasdaq
- AZTA Nasdaq
- Market Cap
- ASTH 1.5B
- AZTA 1.4B
- IPO Year
- ASTH N/A
- AZTA 1995
- Fundamental
- Price
- ASTH $33.89
- AZTA $29.12
- Analyst Decision
- ASTH Strong Buy
- AZTA Strong Buy
- Analyst Count
- ASTH 5
- AZTA 5
- Target Price
- ASTH $47.40
- AZTA $41.20
- AVG Volume (30 Days)
- ASTH 339.8K
- AZTA 459.7K
- Earning Date
- ASTH 11-06-2025
- AZTA 11-10-2025
- Dividend Yield
- ASTH N/A
- AZTA N/A
- EPS Growth
- ASTH N/A
- AZTA N/A
- EPS
- ASTH 0.52
- AZTA N/A
- Revenue
- ASTH $2,419,115,000.00
- AZTA $668,821,000.00
- Revenue This Year
- ASTH $60.87
- AZTA N/A
- Revenue Next Year
- ASTH $27.04
- AZTA $4.10
- P/E Ratio
- ASTH $63.56
- AZTA N/A
- Revenue Growth
- ASTH 51.97
- AZTA 12.46
- 52 Week Low
- ASTH $21.20
- AZTA $23.91
- 52 Week High
- ASTH $60.99
- AZTA $55.64
- Technical
- Relative Strength Index (RSI)
- ASTH 62.91
- AZTA 41.09
- Support Level
- ASTH $32.19
- AZTA $29.03
- Resistance Level
- ASTH $33.90
- AZTA $30.81
- Average True Range (ATR)
- ASTH 1.27
- AZTA 1.26
- MACD
- ASTH -0.01
- AZTA -0.22
- Stochastic Oscillator
- ASTH 76.39
- AZTA 5.16
About ASTH Astrana Health Inc. Common Stock
Astrana Health Inc is a patient-centered, physician-centric integrated population health management company. The company is working to provide coordinated, outcomes-based medical care cost-effectively. It is focused on physicians providing high-quality medical care, population health management, and care coordination for patients, particularly senior patients and patients with multiple chronic conditions. The company's three reportable segments are Care Partners, Care Delivery, and Care Enablement. It generates the majority of its revenue from the Care Partners segment.
About AZTA Azenta Inc.
Azenta Inc is a provider of life sciences solutions, enabling impactful breakthroughs and therapies to market faster. It provides a full suite of reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and cell therapies for the industry's top pharmaceutical, biotech, academic and healthcare institutions globally. The company has three reportable segments that are Sample Management Solutions, Multiomics, and B Medical Systems. It generates a substantial part of its revenue from its Sample Management Solutions segment.